Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)

Hamostaseologie. 2020 Dec;40(5):572-590. doi: 10.1055/a-1132-0750. Epub 2020 Jun 26.


Venous thromboembolism (VTE) is a major cause of maternal morbidity during pregnancy and the postpartum period. Because there is a lack of adequate study data, management strategies for the prevention of VTE during pregnancy have mainly been deduced from case-control and observational studies and extrapolated from recommendations for non-pregnant patients. The decision for or against pharmacologic thromboprophylaxis must be made on an individual basis weighing the risk of VTE against the risk of adverse side effects such as severe bleeding complications. A comprehensive, multidisciplinary approach is often essential as the clinical scenario is made more complex by the specific obstetric context, especially in the peripartum period. As members of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH), we summarize the evidence from the available literature and aim to establish a more uniform strategy for VTE risk assessment and thromboprophylaxis in pregnancy and the puerperium. In this document, we focus on women with hereditary thrombophilia, prior VTE and the use of anticoagulants that can safely be applied during pregnancy and the lactation period.

Publication types

  • Review

MeSH terms

  • Female
  • Hemostasis / physiology*
  • Humans
  • Postpartum Period
  • Pregnancy
  • Risk Assessment
  • Risk Factors
  • Thrombophilia / complications*
  • Thrombosis / physiopathology*
  • Venous Thromboembolism / prevention & control*
  • Women's Health

Supplementary concepts

  • Thrombophilia, hereditary